최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기International neurourology journal : INJ, v.18 no.3, 2014년, pp.155 - 162
Lee, Ho Won (Department of Urology, Hanyang University College of Medicine, Seoul, Korea.) , Kim, Shin Ah (Institute for Health and Society, Hanyang University College of Medicine, Seoul, Korea.) , Nam, Ji Won (Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea.) , Kim, Mi Kyung (Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea.) , Choi, Bo Youl (Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea.) , Moon, Hong Sang (Department of Urology, Hanyang University College of Medicine, Seoul, Korea.)
PurposeThe number of benign prostatic hyperplasia (BPH) subjects has been increasing worldwide, and many studies have been conducted to determine the treatment that can delay drug therapy or surgery. Subsequently, most of these studies involved physical activity (PA) and associated factors. Therefor...
1 Parsons JK Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems J Urol 2007 178 395 401 17561143
2 Park HK Park H Cho SY Bae J Jeong SJ Hong SK The prevalence of benign prostatic hyperplasia in elderly men in Korea: a community-based study Korean J Urol 2009 50 843 847
3 McVary KT BPH: epidemiology and comorbidities Am J Manag Care 2006 12 5 Suppl S122 S128 16613526
4 Irwin DE Kopp ZS Agatep B Milsom I Abrams P Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction BJU Int 2011 108 1132 1138 21231991
5 Groves HK Chang D Palazzi K Cohen S Parsons JK The incidence of acute urinary retention secondary to BPH is increasing among California men Prostate Cancer Prostatic Dis 2013 16 260 265 23648398
6 Hollingsworth JM Wilt TJ Lower urinary tract symptoms in men BMJ 2014 349 g4474 25125424
7 Lepor H Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia Rev Urol 2004 6 Suppl 9 S3 S10
8 Caine M The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy J Urol 1986 136 1 4 2423716
9 Parsons JK Im R Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia J Urol 2009 182 1463 1468 19683313
10 Cui Y Zong H Yan H Li N Zhang Y Degarelix versus goserelin plus bicalutamide therapy for lower urinary tract symptom relief, prostate volume reduction and quality of life improvement in men with prostate cancer: a systematic review and meta-analysis Urol Int 2014 93 152 159 24603064
11 Parsons JK Kashefi C Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms Eur Urol 2008 53 1228 1235 18358592
12 Rohrmann S Crespo CJ Weber JR Smit E Giovannucci E Platz EA Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey BJU Int 2005 96 77 82 15963125
13 Seim A Hoyo C Ostbye T Vatten L The prevalence and correlates of urinary tract symptoms in Norwegian men: the HUNT study BJU Int 2005 96 88 92 15963127
14 Schoenfeld MJ Shortridge EF Gelwicks SC Cui Z Wong DG Treatment patterns in alpha-blocker therapy for benign prostatic hyperplasia Am J Mens Health 2014 8 267 272 24262787
15 Meigs JB Mohr B Barry MJ Collins MM McKinlay JB Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men J Clin Epidemiol 2001 54 935 944 11520654
16 Giovannucci E Rimm EB Chute CG Kawachi I Colditz GA Stampfer MJ Obesity and benign prostatic hyperplasia Am J Epidemiol 1994 140 989 1002 7527182
17 Sallis JF Haskell WL Wood PD Fortmann SP Rogers T Blair SN Physical activity assessment methodology in the Five-City Project Am J Epidemiol 1985 121 91 106 3964995
18 Platz EA Kawachi I Rimm EB Colditz GA Stampfer MJ Willett WC Physical activity and benign prostatic hyperplasia Arch Intern Med 1998 158 2349 2356 9827786
19 Speakman M Kirby R Doyle S Ioannou C Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK BJU Int 2014 3 24 [Epub]. http://dx.doi.org/10.1111/bju.12745
20 Hootman JM 2008 Physical Activity Guidelines for Americans: an opportunity for athletic trainers J Athl Train 2009 44 5 6 19180212
21 Gass R Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake BJU Int 2002 90 649 654 12410741
22 Gacci M Corona G Vignozzi L Salvi M Serni S De Nunzio C Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis BJU Int 2014 3 06 [Epub]. http://dx.doi.org/10.1111/bju.12728
23 Abdollah F Briganti A Suardi N Castiglione F Gallina A Capitanio U Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention Korean J Urol 2011 52 507 516 21927696
24 Brown DW Brown DR Heath GW Balluz L Giles WH Ford ES Associations between physical activity dose and health-related quality of life Med Sci Sports Exerc 2004 36 890 896 15126726
25 Vignozzi L Rastrelli G Corona G Gacci M Forti G Maggi M Benign prostatic hyperplasia: a new metabolic disease? J Endocrinol Invest 2014 1 24 [Epub]. http://dx.doi.org/10.1111/bju.12728
※ AI-Helper는 부적절한 답변을 할 수 있습니다.